<!DOCTYPE HTML SYSTEM "HTML4.DTD" >
<HTML>
<HEAD>
<TITLE>ICD-10: Block E70-E90
</TITLE>
<LINK HREF="style.css" REL="stylesheet" TYPE="text/css">
<META NAME="AUTHOR" CONTENT="Michael Schopen">
<META NAME="DESCRIPTION" CONTENT="International Statistical Classification of Diseases and Related Health Problems (ICD-10). HTML files for WWW.">
<META NAME="KEYWORDS" CONTENT="ICD-10; tabular list;chapter IV">
<META NAME="COPYRIGHT" CONTENT="WHO">
<META NAME="ROBOTS" CONTENT="index, follow">
<SCRIPT TYPE="text/JavaScript">
  function openSub(URL) {
    var SUB = window.open(URL, "SUB", "dependent=1,height=200,width=500,resizable=1,scrollbars=1") ;
    SUB.focus() ;
  }
</SCRIPT>
<SCRIPT TYPE="text/JavaScript">
function setNavi(url,hash) {
  if (window.name != "SUB") {
    if ((parent.location.href == self.location.href) || (!parent.correct_frame)) {
      window.location.replace('fr-icd.htm?'+url+'+'+hash) ;
    }
    else {
      with (parent.navi.document) {
        open('text/html','replace') ;
        writeln('<HEAD>') ;
        writeln('<TITLE>Navigational frame work ICD-10</TITLE>') ;
        writeln('<link href="style.css" rel="stylesheet" type="text/css">') ;
        writeln('</HEAD>') ;
        writeln('<BODY BGCOLOR="#000080">') ;
        writeln('<table border="0" cellpadding="4" cellspacing="4" width="100%">') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="navi.htm#ka00">List&nbsp;of&nbsp;Chapters</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="ke00.htm">Chapter&nbsp;Introduction</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="ke00.htm#glied">List&nbsp;of&nbsp;Blocks</A></td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="text" HREF="ge65.htm">Previous&nbsp;Block</A></td></tr>') ;
        writeln('<tr><td>&nbsp;</td></tr>') ;
        writeln('<tr><td class="navsub"><A class="nav" TARGET="_top" HREF="http://www.who.int/classifications/icd">ICD Homepage</A></td></tr></table>') ;
        close() ;
      }
    }
  }
}
</SCRIPT>

</HEAD>

<BODY BGCOLOR="#FFFFFF" onLoad="setNavi('ge70.htm',window.location.hash.substring(1))">

<H1>Chapter IV
<BR>
<HR>Endocrine, nutritional and metabolic diseases
<BR>(E00-E90)
</H1>
<H2>Metabolic disorders
<BR>(E70-E90)
</H2>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="8">androgen resistance syndrome 
<NOBR>(
<A HREF="ge20.htm#e345">E34.5
</A>)
</NOBR>
<BR>congenital adrenal hyperplasia 
<NOBR>(
<A HREF="ge20.htm#e250">E25.0
</A>)
</NOBR>
<BR>Ehlers-Danlos syndrome 
<NOBR>(
<A HREF="gq65.htm#q796">Q79.6
</A>)
</NOBR>
<BR>haemolytic anaemias due to enzyme disorders 
<NOBR>(
<A HREF="gd55.htm#d55">D55.-
</A>)
</NOBR>
<BR>Marfan's syndrome 
<NOBR>(
<A HREF="gq80.htm#q874">Q87.4
</A>)
</NOBR>
<BR>5-alpha-reductase deficiency 
<NOBR>(
<A HREF="ge20.htm#e291">E29.1
</A>)
</NOBR>
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e70">
</A>E70
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of aromatic amino-acid metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e700">
</A>E70.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Classical phenylketonuria
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e701">
</A>E70.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other hyperphenylalaninaemias
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e702">
</A>E70.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of tyrosine metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Alkaptonuria
<BR>Hypertyrosinaemia
<BR>Ochronosis
<BR>Tyrosinaemia
<BR>Tyrosinosis
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e703">
</A>E70.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Albinism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Albinism:
<BR>&middot; ocular
<BR>&middot; oculocutaneous
<BR>Syndrome:
<BR>&middot; Chediak(-Steinbrinck)-Higashi
<BR>&middot; Cross
<BR>&middot; Hermansky-Pudlak
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e708">
</A>E70.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other disorders of aromatic amino-acid metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Disorders of:
<BR>&middot; histidine metabolism
<BR>&middot; tryptophan metabolism
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e709">
</A>E70.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorder of aromatic amino-acid metabolism, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e71">
</A>E71
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e710">
</A>E71.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Maple-syrup-urine disease
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e711">
</A>E71.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other disorders of branched-chain amino-acid metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Hyperleucine-isoleucinaemia
<BR>Hypervalinaemia
<BR>Isovaleric acidaemia
<BR>Methylmalonic acidaemia
<BR>Propionic acidaemia
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e712">
</A>E71.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorder of branched-chain amino-acid metabolism, unspecified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e713">
</A>E71.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of fatty-acid metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Adrenoleukodystrophy [Addison-Schilder]
<BR>Muscle carnitine palmityltransferase deficiency
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">Refsum's disease 
<NOBR>(
<A HREF="gg60.htm#g601">G60.1
</A>)
</NOBR>
<BR>Schilder's disease 
<NOBR>(
<A HREF="gg35.htm#g370">G37.0
</A>)
</NOBR>
<BR>Zellweger's syndrome 
<NOBR>(
<A HREF="gq80.htm#q878">Q87.8
</A>)
</NOBR>
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e72">
</A>E72
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other disorders of amino-acid metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">abnormal findings without manifest disease 
<NOBR>(
<A HREF="gr70.htm#r70">R70-R89
</A>)
</NOBR>
<BR>disorders of:
<BR>&middot; aromatic amino-acid metabolism 
<NOBR>(
<A HREF="#e70">E70.-
</A>)
</NOBR>
<BR>&middot; branched-chain amino-acid metabolism 
<NOBR>(
<A HREF="#e710">E71.0-E71.2
</A>)
</NOBR>
<BR>&middot; fatty-acid metabolism 
<NOBR>(
<A HREF="#e713">E71.3
</A>)
</NOBR>
<BR>&middot; purine and pyrimidine metabolism 
<NOBR>(
<A HREF="#e79">E79.-
</A>)
</NOBR>
<BR>gout 
<NOBR>(
<A HREF="gm05.htm#m10">M10.-
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e720">
</A>E72.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of amino-acid transport
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Cystinosis
<BR>Cystinuria
<BR>Fanconi(-de Toni)(-Debr&eacute;) syndrome
<BR>Hartnup's disease
<BR>Lowe's syndrome
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">disorders of tryptophan metabolism 
<NOBR>(
<A HREF="#e708">E70.8
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e721">
</A>E72.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of sulfur-bearing amino-acid metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Cystathioninuria
<BR>Homocystinuria
<BR>Methioninaemia
<BR>Sulfite oxidase deficiency
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">transcobalamin II deficiency 
<NOBR>(
<A HREF="gd50.htm#d512">D51.2
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e722">
</A>E72.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of urea cycle metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Argininaemia
<BR>Argininosuccinic aciduria
<BR>Citrullinaemia
<BR>Hyperammonaemia
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">disorders of ornithine metabolism 
<NOBR>(
<A HREF="#e724">E72.4
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e723">
</A>E72.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of lysine and hydroxylysine metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Glutaric aciduria
<BR>Hydroxylysinaemia
<BR>Hyperlysinaemia
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e724">
</A>E72.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of ornithine metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Ornithinaemia (types I, II)
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e725">
</A>E72.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of glycine metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Hyperhydroxyprolinaemia
<BR>Hyperprolinaemia (types I, II)
<BR>Non-ketotic hyperglycinaemia
<BR>Sarcosinaemia
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e728">
</A>E72.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other specified disorders of amino-acid metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Disorders of:
<BR>&middot; Beta-amino-acid metabolism
<BR>&middot; Gamma-glutamyl cycle
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e729">
</A>E72.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorder of amino-acid metabolism, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e73">
</A>E73
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Lactose intolerance
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e730">
</A>E73.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Congenital lactase deficiency
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e731">
</A>E73.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Secondary lactase deficiency
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e738">
</A>E73.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other lactose intolerance
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e739">
</A>E73.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Lactose intolerance, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e74">
</A>E74
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other disorders of carbohydrate metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">increased secretion of glucagon 
<NOBR>(
<A HREF="ge15.htm#e163">E16.3
</A>)
</NOBR>
<BR>diabetes mellitus 
<NOBR>(
<A HREF="ge10.htm#e10">E10-E14
</A>)
</NOBR>
<BR>hypoglycaemia NOS 
<NOBR>(
<A HREF="ge15.htm#e162">E16.2
</A>)
</NOBR>
<BR>mucopolysaccharidosis 
<NOBR>(
<A HREF="#e760">E76.0-E76.3
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e740">
</A>E74.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Glycogen storage disease
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Cardiac glycogenosis
<BR>Disease:
<BR>&middot; Andersen
<BR>&middot; Cori
<BR>&middot; Forbes
<BR>&middot; Hers
<BR>&middot; McArdle
<BR>&middot; Pompe
<BR>&middot; Tauri
<BR>&middot; von Gierke
<BR>Liver phosphorylase deficiency
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e741">
</A>E74.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of fructose metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Essential fructosuria
<BR>Fructose-1,6-diphosphatase deficiency
<BR>Hereditary fructose intolerance
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e742">
</A>E74.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of galactose metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Galactokinase deficiency
<BR>Galactosaemia
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e743">
</A>E74.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other disorders of intestinal carbohydrate absorption
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Glucose-galactose malabsorption
<BR>Sucrase deficiency
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">lactose intolerance 
<NOBR>(
<A HREF="#e73">E73.-
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e744">
</A>E74.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of pyruvate metabolism and gluconeogenesis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Deficiency of:
<BR>&middot; phosphoenolpyruvate carboxykinase
<BR>&middot; pyruvate:
<BR>&nbsp;&nbsp;&middot; carboxylase
<BR>&nbsp;&nbsp;&middot; dehydrogenase
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">with anaemia 
<NOBR>(
<A HREF="gd55.htm#d55">D55.-
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e748">
</A>E74.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other specified disorders of carbohydrate metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Essential pentosuria
<BR>Oxalosis
<BR>Oxaluria
<BR>Renal glycosuria
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e749">
</A>E74.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorder of carbohydrate metabolism, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e75">
</A>E75
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of sphingolipid metabolism and other lipid storage disorders
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">mucolipidosis, types I-III 
<NOBR>(
<A HREF="#e770">E77.0-E77.1
</A>)
</NOBR>
<BR>Refsum's disease 
<NOBR>(
<A HREF="gg60.htm#g601">G60.1
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e750">
</A>E75.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>GM
<SUB>2
</SUB> gangliosidosis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Disease:
<BR>&middot; Sandhoff
<BR>&middot; Tay-Sachs
<BR>GM
<SUB>2
</SUB> gangliosidosis:
<BR>&middot; NOS
<BR>&middot; adult
<BR>&middot; juvenile
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e751">
</A>E75.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other gangliosidosis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Gangliosidosis:
<BR>&middot; NOS
<BR>&middot; GM
<SUB>1
</SUB>
<BR>&middot; GM
<SUB>3
</SUB>
<BR>Mucolipidosis IV
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e752">
</A>E75.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other sphingolipidosis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Disease:
<BR>&middot; Fabry(-Anderson)
<BR>&middot; Gaucher
<BR>&middot; Krabbe
<BR>&middot; Niemann-Pick
<BR>Faber's syndrome
<BR>Metachromatic leukodystrophy
<BR>Sulfatase deficiency
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">adrenoleukodystrophy [Addison-Schilder] 
<NOBR>(
<A HREF="#e713">E71.3
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e753">
</A>E75.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Sphingolipidosis, unspecified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e754">
</A>E75.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Neuronal ceroid lipofuscinosis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Disease:
<BR>&middot; Batten
<BR>&middot; Bielschowsky-Jansky
<BR>&middot; Kufs
<BR>&middot; Spielmeyer-Vogt
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e755">
</A>E75.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other lipid storage disorders
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Cerebrotendinous cholesterosis [van Bogaert-Scherer-Epstein]
<BR>Wolman's disease
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e756">
</A>E75.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Lipid storage disorder, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e76">
</A>E76
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of glycosaminoglycan metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e760">
</A>E76.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Mucopolysaccharidosis, type I
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Syndrome:
<BR>&middot; Hurler
<BR>&middot; Hurler-Scheie
<BR>&middot; Scheie
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e761">
</A>E76.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Mucopolysaccharidosis, type II
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Hunter's syndrome
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e762">
</A>E76.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other mucopolysaccharidoses
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Beta-glucuronidase deficiency
<BR>Mucopolysaccharidosis, types III, IV, VI, VII
<BR>Syndrome:
<BR>&middot; Maroteaux-Lamy (mild)(severe)
<BR>&middot; Morquio(-like)(classic)
<BR>&middot; Sanfilippo (type B)(type C)(type D)
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e763">
</A>E76.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Mucopolysaccharidosis, unspecified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e768">
</A>E76.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other disorders of glucosaminoglycan metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e769">
</A>E76.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorder of glucosaminoglycan metabolism, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e77">
</A>E77
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of glycoprotein metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e770">
</A>E77.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Defects in post-translational modification of lysosomal enzymes
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Mucolipidosis II [I-cell disease]
<BR>Mucolipidosis III [pseudo-Hurler polydystrophy]
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e771">
</A>E77.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Defects in glycoprotein degradation
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Aspartylglucosaminuria
<BR>Fucosidosis
<BR>Mannosidosis
<BR>Sialidosis [mucolipidosis I]
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e778">
</A>E77.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other disorders of glycoprotein metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e779">
</A>E77.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorder of glycoprotein metabolism, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e78">
</A>E78
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of lipoprotein metabolism and other lipidaemias
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">sphingolipidosis 
<NOBR>(
<A HREF="#e750">E75.0-E75.3
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e780">
</A>E78.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Pure hypercholesterolaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Familial hypercholesterolaemia
<BR>Fredrickson's hyperlipoproteinaemia, type IIa
<BR>Hyperbetalipoproteinaemia
<BR>Hyperlipidaemia, group A
<BR>Low-density-lipoprotein-type [LDL] hyperlipoproteinaemia
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e781">
</A>E78.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Pure hyperglyceridaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Endogenous hyperglyceridaemia
<BR>Fredrickson's hyperlipoproteinaemia, type IV
<BR>Hyperlipidaemia, group B
<BR>Hyperprebetalipoproteinaemia
<BR>Very-low-density-lipoprotein-type [VLDL] hyperlipoproteinaemia
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e782">
</A>E78.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Mixed hyperlipidaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Broad- or floating-betalipoproteinaemia
<BR>Fredrickson's hyperlipoproteinaemia, type IIb or III
<BR>Hyperbetalipoproteinaemia with prebetalipoproteinaemia
<BR>Hypercholesterolaemia with endogenous hyperglyceridaemia
<BR>Hyperlipidaemia, group C
<BR>Tubero-eruptive xanthoma
<BR>Xanthoma tuberosum
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">cerebrotendinous cholesterosis [van Bogaert-Scherer-Epstein] 
<NOBR>(
<A HREF="#e755">E75.5
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e783">
</A>E78.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hyperchylomicronaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Fredrickson's hyperlipoproteinaemia, type I or V
<BR>Hyperlipidaemia, group D
<BR>Mixed hyperglyceridaemia
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e784">
</A>E78.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other hyperlipidaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Familial combined hyperlipidaemia
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e785">
</A>E78.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hyperlipidaemia, unspecified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e786">
</A>E78.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Lipoprotein deficiency
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Abetalipoproteinaemia
<BR>High-density lipoprotein deficiency
<BR>Hypoalphalipoproteinaemia
<BR>Hypobetalipoproteinaemia (familial)
<BR>Lecithin cholesterol acyltransferase deficiency
<BR>Tangier disease
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e788">
</A>E78.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other disorders of lipoprotein metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e789">
</A>E78.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorder of lipoprotein metabolism, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e79">
</A>E79
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of purine and pyrimidine metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">calculus of kidney 
<NOBR>(
<A HREF="gn20.htm#n200">N20.0
</A>)
</NOBR>
<BR>combined immunodeficiency disorders 
<NOBR>(
<A HREF="gd80.htm#d81">D81.-
</A>)
</NOBR>
<BR>gout 
<NOBR>(
<A HREF="gm05.htm#m10">M10.-
</A>)
</NOBR>
<BR>orotaciduric anaemia 
<NOBR>(
<A HREF="gd50.htm#d530">D53.0
</A>)
</NOBR>
<BR>xeroderma pigmentosum 
<NOBR>(
<A HREF="gq80.htm#q821">Q82.1
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e790">
</A>E79.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Asymptomatic hyperuricaemia
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e791">
</A>E79.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Lesch-Nyhan syndrome
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e798">
</A>E79.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other disorders of purine and pyrimidine metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Hereditary xanthinuria
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e799">
</A>E79.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorder of purine and pyrimidine metabolism, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e80">
</A>E80
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of porphyrin and bilirubin metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">defects of catalase and peroxidase
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e800">
</A>E80.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hereditary erythropoietic porphyria
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Congenital erythropoietic porphyria
<BR>Erythropoietic protoporphyria
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e801">
</A>E80.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Porphyria cutanea tarda
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e802">
</A>E80.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other porphyria
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Hereditary coproporphyria
<BR>Porphyria:
<BR>&middot; NOS
<BR>&middot; acute intermittent (hepatic)
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Use additional external cause code (Chapter XX), if desired, to identify cause.
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e803">
</A>E80.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Defects of catalase and peroxidase
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Acatalasia [Takahara]
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e804">
</A>E80.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Gilbert's syndrome
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e805">
</A>E80.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Crigler-Najjar syndrome
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e806">
</A>E80.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other disorders of bilirubin metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Dubin-Johnson syndrome
<BR>Rotor's syndrome
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e807">
</A>E80.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorder of bilirubin metabolism, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e83">
</A>E83
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of mineral metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">dietary mineral deficiency 
<NOBR>(
<A HREF="ge50.htm#e58">E58-E61
</A>)
</NOBR>
<BR>parathyroid disorders 
<NOBR>(
<A HREF="ge20.htm#e20">E20-E21
</A>)
</NOBR>
<BR>vitamin D deficiency 
<NOBR>(
<A HREF="ge50.htm#e55">E55.-
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e830">
</A>E83.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of copper metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Menkes' (kinky hair)(steely hair) disease
<BR>Wilson's disease
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e831">
</A>E83.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of iron metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Haemochromatosis
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">anaemia:
<BR>&middot; iron deficiency 
<NOBR>(
<A HREF="gd50.htm#d50">D50.-
</A>)
</NOBR>
<BR>&middot; sideroblastic 
<NOBR>(
<A HREF="gd60.htm#d640">D64.0-D64.3
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e832">
</A>E83.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of zinc metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Acrodermatitis enteropathica
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e833">
</A>E83.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of phosphorus metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Acid phosphatase deficiency
<BR>Familial hypophosphataemia
<BR>Hypophosphatasia
<BR>Vitamin-D-resistant:
<BR>&middot; osteomalacia
<BR>&middot; rickets
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">adult osteomalacia 
<NOBR>(
<A HREF="gm80.htm#m83">M83.-
</A>)
</NOBR>
<BR>osteoporosis 
<NOBR>(
<A HREF="gm80.htm#m80">M80-M81
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e834">
</A>E83.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of magnesium metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Hypermagnesaemia
<BR>Hypomagnesaemia
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e835">
</A>E83.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of calcium metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Familial hypocalciuric hypercalcaemia
<BR>Idiopathic hypercalciuria
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">chondrocalcinosis 
<NOBR>(
<A HREF="gm05.htm#m111">M11.1-M11.2
</A>)
</NOBR>
<BR>hyperparathyroidism 
<NOBR>(
<A HREF="ge20.htm#e210">E21.0-E21.3
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e838">
</A>E83.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other disorders of mineral metabolism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e839">
</A>E83.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorder of mineral metabolism, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e84">
</A>E84
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Cystic fibrosis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Includes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">mucoviscidosis
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e840">
</A>E84.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Cystic fibrosis with pulmonary manifestations
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e841">
</A>E84.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Cystic fibrosis with intestinal manifestations
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Meconium ileus+ 
<NOBR>(
<A HREF="gp75.htm#p75">P75*
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">meconium obstruction in cases where cystic fibrosis is known not to be present 
<NOBR>(
<A HREF="gp75.htm#p769">P76.0
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e848">
</A>E84.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Cystic fibrosis with other manifestations
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Cystic fibrosis with combined manifestations
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e849">
</A>E84.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Cystic fibrosis, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e85">
</A>E85
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Amyloidosis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">Alzheimer's disease 
<NOBR>(
<A HREF="gg30.htm#g30">G30.-
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e850">
</A>E85.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Non-neuropathic heredofamilial amyloidosis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Familial Mediterranean fever
<BR>Hereditary amyloid nephropathy
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e851">
</A>E85.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Neuropathic heredofamilial amyloidosis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Amyloid polyneuropathy (Portuguese)
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e852">
</A>E85.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Heredofamilial amyloidosis, unspecified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e853">
</A>E85.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Secondary systemic amyloidosis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Haemodialysis-associated amyloidosis
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e854">
</A>E85.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Organ-limited amyloidosis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Localized amyloidosis
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e858">
</A>E85.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other amyloidosis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e859">
</A>E85.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Amyloidosis, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e86">
</A>E86
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Volume depletion
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Dehydration
<BR>Depletion of volume of plasma or extracellular fluid
<BR>Hypovolaemia
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">dehydration of newborn 
<NOBR>(
<A HREF="gp70.htm#p741">P74.1
</A>)
</NOBR>
<BR>hypovolaemic shock:
<BR>&middot; NOS 
<NOBR>(
<A HREF="gr50.htm#r571">R57.1
</A>)
</NOBR>
<BR>&middot; postoperative 
<NOBR>(
<A HREF="gt80.htm#t811">T81.1
</A>)
</NOBR>
<BR>&middot; traumatic 
<NOBR>(
<A HREF="gt79.htm#t794">T79.4
</A>)
</NOBR>
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e87">
</A>E87
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other disorders of fluid, electrolyte and acid-base balance
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e870">
</A>E87.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hyperosmolality and hypernatraemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Sodium [Na] excess
<BR>Sodium [Na] overload
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e871">
</A>E87.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hypo-osmolality and hyponatraemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Sodium [Na] deficiency
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">Syndrome of inappropriate secretion of antidiuretic hormone 
<NOBR>(
<A HREF="ge20.htm#e222">E22.2
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e872">
</A>E87.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Acidosis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Acidosis:
<BR>&middot; NOS
<BR>&middot; lactic
<BR>&middot; metabolic
<BR>&middot; respiratory
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">diabetic acidosis 
<NOBR>(
<A HREF="ge10.htm#e10">E10-E14
</A> with common fourth character .1)
</NOBR>
<BR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e873">
</A>E87.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Alkalosis
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Alkalosis:
<BR>&middot; NOS
<BR>&middot; metabolic
<BR>&middot; respiratory
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e874">
</A>E87.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Mixed disorder of acid-base balance
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e875">
</A>E87.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hyperkalaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Potassium [K] excess
<BR>Potassium [K] overload
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e876">
</A>E87.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Hypokalaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Potassium [K] deficiency
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e877">
</A>E87.7
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Fluid overload
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">oedema 
<NOBR>(
<A HREF="gr50.htm#r60">R60.-
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e878">
</A>E87.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other disorders of electrolyte and fluid balance, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Electrolyte imbalance NOS
<BR>Hyperchloraemia
<BR>Hypochloraemia
<BR>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e88">
</A>E88
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other metabolic disorders
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced.
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">histiocytosis X (chronic) 
<NOBR>(
<A HREF="gd70.htm#d760">D76.0
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e880">
</A>E88.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Disorders of plasma-protein metabolism, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Alpha-1-antitrypsin deficiency
<BR>Bisalbuminaemia
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">disorder of lipoprotein metabolism 
<NOBR>(
<A HREF="#e78">E78.-
</A>)
</NOBR>
<BR>monoclonal gammopathy 
<NOBR>(
<A HREF="gd37.htm#d472">D47.2
</A>)
</NOBR>
<BR>polyclonal hypergammaglobulinaemia 
<NOBR>(
<A HREF="gd80.htm#d890">D89.0
</A>)
</NOBR>
<BR>Waldenstr&ouml;m's macroglobulinaemia 
<NOBR>(
<A HREF="gc81.htm#c880">C88.0
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e881">
</A>E88.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Lipodystrophy, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Lipodystrophy NOS
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="5%">
<EM>
<STRONG>Excludes:
</STRONG>
</EM>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="6">Whipple's disease 
<NOBR>(
<A HREF="gk90.htm#k908">K90.8
</A>)
</NOBR>
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e882">
</A>E88.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Lipomatosis, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Lipomatosis:
<BR>&middot; NOS
<BR>&middot; dolorosa [Dercum]
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e888">
</A>E88.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other specified metabolic disorders
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Launois-Bensaude adenolipomatosis
<BR>Trimethylaminuria
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e889">
</A>E88.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Metabolic disorder, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e89">
</A>E89
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Postprocedural endocrine and metabolic disorders, not elsewhere classified
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e890">
</A>E89.0
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Postprocedural hypothyroidism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Postirradiation hypothyroidism
<BR>Postsurgical hypothyroidism
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e891">
</A>E89.1
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Postprocedural hypoinsulinaemia
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Postpancreatectomy hyperglycaemia
<BR>Postsurgical hypoinsulinaemia
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e892">
</A>E89.2
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Postprocedural hypoparathyroidism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Parathyroprival tetany
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e893">
</A>E89.3
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Postprocedural hypopituitarism
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">Postirradiation hypopituitarism
<BR>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e894">
</A>E89.4
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Postprocedural ovarian failure
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e895">
</A>E89.5
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Postprocedural testicular hypofunction
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e896">
</A>E89.6
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Postprocedural adrenocortical(-medullary) hypofunction
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e898">
</A>E89.8
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Other postprocedural endocrine and metabolic disorders
</STRONG>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%">
<STRONG>
<A NAME="e899">
</A>E89.9
</STRONG>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Postprocedural endocrine and metabolic disorder, unspecified
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<TABLE BORDER="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">
</TD>
<TD WIDTH="3%">
</TD>
<TD WIDTH="8%">
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
<TD>
</TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="8%" BGCOLOR="BLACK">
<span class="white">
<STRONG>
<A NAME="e90">
</A>E90*
</STRONG>
</span>
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="3%">
</TD>
<TD VALIGN="TOP" ALIGN="LEFT" COLSPAN="7">
<STRONG>Nutritional and metabolic disorders in diseases classified elsewhere
</STRONG>
</TD>
</TR>
</TABLE>
<P>
</P>
<HR>
<TABLE BORDER="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD VALIGN="TOP" ALIGN="LEFT" WIDTH="33%">Processed on 03.06.2003 
<A HREF="mailto:schopen@dimdi.de">M.S.
</A>
</TD>
<TD VALIGN="TOP" ALIGN="CENTER" WIDTH="34%">Source: World Health Organization
</TD>
<TD VALIGN="TOP" ALIGN="RIGHT" WIDTH="33%">&copy; Copyright WHO 1994/2003
</TD>
</TR>
</TABLE>
</BODY >
</HTML>
